View patent here
Related Posts
Raymond James Maintains Strong Buy on TPG RE Finance Trust, Raises Price Target to $16
Raymond James analyst Stephen Laws maintains TPG RE Finance Trust (NYSE:TRTX) with a Strong Buy and raises the price target from $15.5 to $16.
Aligos Therapeutics Q2 EPS $(0.79) Beats $(0.81) Estimate
Aligos Therapeutics (NASDAQ:ALGS) reported quarterly losses of $(0.79) per share which beat the analyst consensus estimate of $(0.81) by 2.47 percent.
Mid-Afternoon Market Update: US Stocks Mostly Flat; DiaMedica Therapeutics Shares Plunge
Toward the end of trading Tuesday, the Dow traded up 0.04% to 34,295.41 while the NASDAQ rose 0.13% to 14,518.98. The S&P traded flat at 4,290.65.